10-Q quarterly report · filed Oct 29, 2026

PRO DEX INC (PDEX) Q3 2026 10-Q Quarterly Report

Short answer

PRO DEX INC (PDEX) filed its Q3 2026 10-Q quarterly report on Oct 29, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $21M (up 11.0% year over year) with net income of $3M.

Q3 2026 key financials · XBRL

Revenue
$21M
+11.0% YoY
Net income
$3M
−34.9% YoY
Operating margin
17.1%
Gross margin
33.4%
EPS (diluted)
$0.92
−34.3% YoY

Source: XBRL data from the PRO DEX INC (PDEX) Q3 2026 10-Q on SEC EDGAR. USD.

PRO DEX INC Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $20.6M, up 11% YoY from $18.5M, led by medical devices at $17.4M
  • Gross margin 33% vs 29% YoY, with gross profit $6.9M vs $5.4M
  • Orthopedic sales $12.8M, up 16%; repair revenue $2.1M, down 44%
  • Cash $11.8M vs $8.2M, operating cash flow $6.5M vs $2.3M
  • Backlog $43.1M, supplier shipment delays risk handpiece deliveries; $11M revolving capacity available

Risk Factors

  • No material changes to risk factors from the June 30, 2026 Form 10-K
  • Carried-forward business risk: factors may adversely affect future financial condition and results
  • Carried-forward disclosure risk: additional uncertainties appear in financial statement notes and MD&A
  • Carried-forward completeness risk: disclosed risks may not include all future business uncertainties

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other PRO DEX INC quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.